By binding to FGFR1, FGF9 activated FAK, AKT and ERK/MAPK signaling pathways to promote tumor cell proliferation and epithelial-mesenchymal transformation (EMT), thereby enhancing tumor cell migration and invasion [61]. The gene discussed is AKT1; the disease is neoplasm.